한국어
English
日本語
中文(简体)
Beoba Tablet 50 mg (Bevagron)
50mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Vibegron is a medication used to relieve symptoms of overactive bladder.
MFDS ingredient code M282714
Vibegron is classified as a beta-3 adrenergic receptor agonist. It is primarily used in the treatment of overactive bladder, relaxing the bladder muscles to improve urinary symptoms. This ingredient is included in medications related to the urogenital system.
Vibegron binds to the beta-3 adrenergic receptors in the bladder, resulting in relaxation of the bladder muscles. This allows the bladder to store more urine, reducing symptoms of overactive bladder such as frequent urination and urgency. It also helps alleviate discomfort during urination.
Approved uses differ by product. Check each product's information for its actual use.
Vibegron has a higher selectivity compared to other beta-3 agonists, resulting in fewer side effects. Additionally, it has a minimal impact on blood pressure, making it relatively safe for use in patients with hypertension. These features distinguish it from similar medications.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.